180 related articles for article (PubMed ID: 38556323)
1. Effects of glucagon-like peptide-1 receptor agonists on spermatogenesis-related gene expression in mouse testis and testis-derived cell lines.
Iida M; Asano A
J Vet Med Sci; 2024 May; 86(5):555-562. PubMed ID: 38556323
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 receptor is expressed in human and rodent testis.
Caltabiano R; Condorelli D; Panza S; Boitani C; Musso N; Ježek D; Memeo L; Colarossi L; Rago V; Mularoni V; Spadola S; Castiglione R; Santoro M; Aquila S; D'Agata R
Andrology; 2020 Nov; 8(6):1935-1945. PubMed ID: 33460247
[TBL] [Abstract][Full Text] [Related]
3. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis.
Cameron-Vendrig A; Reheman A; Siraj MA; Xu XR; Wang Y; Lei X; Afroze T; Shikatani E; El-Mounayri O; Noyan H; Weissleder R; Ni H; Husain M
Diabetes; 2016 Jun; 65(6):1714-23. PubMed ID: 26936963
[TBL] [Abstract][Full Text] [Related]
5. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
6.
Li W; Li P; Li R; Yu Z; Sun X; Ji G; Yang X; Zhu L; Zhu S
DNA Cell Biol; 2020 Sep; 39(9):1700-1710. PubMed ID: 32721233
[TBL] [Abstract][Full Text] [Related]
7. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
[TBL] [Abstract][Full Text] [Related]
8. An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.
Madsbad S; Kielgast U; Asmar M; Deacon CF; Torekov SS; Holst JJ
Diabetes Obes Metab; 2011 May; 13(5):394-407. PubMed ID: 21208359
[TBL] [Abstract][Full Text] [Related]
9. Gossypol Induces Disruption of Spermatogenesis and Steroidogenesis in Male Mice.
Lim W; Ham J; Park S; Bae H; You S; Song G
J Agric Food Chem; 2019 Feb; 67(7):2075-2085. PubMed ID: 30678458
[TBL] [Abstract][Full Text] [Related]
10. Development and characterisation of a novel glucagon like peptide-1 receptor antibody.
Biggs EK; Liang L; Naylor J; Madalli S; Collier R; Coghlan MP; Baker DJ; Hornigold DC; Ravn P; Reimann F; Gribble FM
Diabetologia; 2018 Mar; 61(3):711-721. PubMed ID: 29119245
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction.
McLean BA; Wong CK; Kabir MG; Drucker DJ
Mol Metab; 2022 Dec; 66():101641. PubMed ID: 36396031
[TBL] [Abstract][Full Text] [Related]
12. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.
Burmeister MA; Ayala JE; Smouse H; Landivar-Rocha A; Brown JD; Drucker DJ; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
Diabetes; 2017 Feb; 66(2):372-384. PubMed ID: 27908915
[TBL] [Abstract][Full Text] [Related]
13. The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide.
Guo XH
Curr Med Res Opin; 2016; 32(1):61-76. PubMed ID: 26439329
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice.
Koehler JA; Baggio LL; Lamont BJ; Ali S; Drucker DJ
Diabetes; 2009 Sep; 58(9):2148-61. PubMed ID: 19509017
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats.
Krieger JP; Santos da Conceição EP; Sanchez-Watts G; Arnold M; Pettersen KG; Mohammed M; Modica S; Lossel P; Morrison SF; Madden CJ; Watts AG; Langhans W; Lee SJ
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R708-R720. PubMed ID: 29847161
[TBL] [Abstract][Full Text] [Related]
17. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
Jia Y; Gong N; Li TF; Zhu B; Wang YX
Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
McKay NJ; Kanoski SE; Hayes MR; Daniels D
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
20. GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy.
Derosa G; Maffioli P
Curr Clin Pharmacol; 2012 Aug; 7(3):214-28. PubMed ID: 22432846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]